These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 11249703)
1. Recent advances in atypical antipsychotics. Armer R; Miller DJ Curr Opin Investig Drugs; 2000 Dec; 1(4):481-93. PubMed ID: 11249703 [No Abstract] [Full Text] [Related]
2. Atypical antipsychotics. Holland D; Watanabe MD; Sharma R Psychiatr Med; 1991; 9(1):5-24. PubMed ID: 1673259 [TBL] [Abstract][Full Text] [Related]
3. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses. Turner MS; Stewart DW J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985 [TBL] [Abstract][Full Text] [Related]
5. Pathophysiology of antipsychotic drug-induced movement disorders. Casey DE J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109 [TBL] [Abstract][Full Text] [Related]
6. Depot antipsychotics in practice. Their rôle in schizophrenia and related psychoses. Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():1-78. PubMed ID: 2881965 [No Abstract] [Full Text] [Related]
7. Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey. Diatta T; Blazejewski S; Portier A; Lignot S; Quesnot A; Moore N; Fourrier-Réglat A Fundam Clin Pharmacol; 2007 Aug; 21(4):371-8. PubMed ID: 17635175 [TBL] [Abstract][Full Text] [Related]
8. The antipsychotics. Harris E Am J Nurs; 1988 Nov; 88(11):1508-11. PubMed ID: 2902800 [No Abstract] [Full Text] [Related]
9. Dexanabinol Pharmos. Pop E Curr Opin Investig Drugs; 2000 Dec; 1(4):494-503. PubMed ID: 11249704 [TBL] [Abstract][Full Text] [Related]
10. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. Kane JM; Leucht S; Carpenter D; Docherty JP; J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142 [TBL] [Abstract][Full Text] [Related]
12. Benefits of atypical antipsychotic medications in the treatment of psychosis. White DL Kans Nurse; 2003; 78(10):1-2. PubMed ID: 14746070 [No Abstract] [Full Text] [Related]
13. [Consumption and cost of antipsychotic drugs]. Pérez J; Marín N; Vallano A; Castells X; Capellà D Actas Esp Psiquiatr; 2005; 33(2):110-6. PubMed ID: 15768318 [TBL] [Abstract][Full Text] [Related]
14. [Schizophrenic psychoses: distinct therapeutic advantages of atypical neuroleptics. Serdolect: effective and free of side effects]. Fortschr Neurol Psychiatr; 1998 Oct; 66(10 Suppl Schizophre):1-4. PubMed ID: 9828949 [No Abstract] [Full Text] [Related]
15. Population pharmacokinetics and dosing of long-acting injectable antipsychotics. Kim DD; Barr AM; Rafizadeh R; Procyshyn RM J Psychiatry Neurosci; 2021 Sep; 46(5):E516-E517. PubMed ID: 34467748 [No Abstract] [Full Text] [Related]
16. Facts about atypical antipsychotics. Cates ME J Am Geriatr Soc; 2006 Feb; 54(2):382-3. PubMed ID: 16460407 [No Abstract] [Full Text] [Related]
17. A controlled, mirror-image study of second-generation antipsychotics in the treatment of schizophrenia. Taylor D; Hayhurst K; Kerwin R Int Clin Psychopharmacol; 2007 May; 22(3):133-6. PubMed ID: 17414738 [TBL] [Abstract][Full Text] [Related]
18. A rational approach to the use of atypical antipsychotics. Belmaker RH; Bersudsky Y Isr J Psychiatry Relat Sci; 2003; 40(2):79-81. PubMed ID: 14509197 [No Abstract] [Full Text] [Related]